ReviewTechnology in cancer research & treatment

Focusing on the Advances and Challenges of HER2-Targeted Therapy: Cutting-Edge Breakthroughs in Neoadjuvant Treatment for HER2-Positive Breast Cancer.

Anqi Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.